Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD Pixium Vision to receive interactive communication…
Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products Court finds Second Sight Medical Products breached 2021…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq:…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq:…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief…
Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities Paris, 21 October…
— FDA feedback marks a key milestone in the construction of the facility expected to support AGTC’s pipeline, including the…
Pixium Vision announces its financial results for H1 2022 and provides a business update Cash position at 30 June 2022:…
Scientists have developed another remarkable innovation that’s helping amputees gain a new lease on life. Once again, researchers have developed…